PubRank

Harry Bleiberg

Author PubWeight™ 54.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004 30.26
2 Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol 2006 3.70
3 Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 2008 3.49
4 Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol 2005 2.47
5 Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis. J Natl Cancer Inst 2013 1.90
6 Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer. BJU Int 2007 1.61
7 Managing older patients with colorectal cancer. J Clin Oncol 2007 1.47
8 Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis. J Natl Cancer Inst 2013 1.28
9 Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. Eur J Cancer 2013 1.24
10 Overall survival is not a realistic end point for clinical trials of new drugs in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer. J Clin Oncol 2003 1.13
11 The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers. BJU Int 2008 0.98
12 Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial. Lancet Oncol 2005 0.88
13 Treatment of hepatocarcinoma. Curr Oncol Rep 2004 0.86
14 Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancer. Semin Oncol 2005 0.84
15 A new computer-aided diagnostic tool for non-invasive characterisation of malignant ovarian masses: results of a multicentre validation study. Eur Radiol 2010 0.82
16 Is FOB screening really the answer for lowering mortality in colorectal cancer? Recent Results Cancer Res 2003 0.82
17 Long-term survival of patients downstaged by oxaliplatin and 5-fluorouracil combination followed by rescue surgery for unresectable colorectal liver metastases. Gastroenterol Clin Biol 2006 0.80
18 OPTIMOX1 in advanced colorectal cancer: lack of evidence for a stop-and-go strategy. J Clin Oncol 2006 0.75
19 Are we cautious enough when we interpret results of randomized but underpowered comparisons? J Clin Oncol 2006 0.75
20 Mortality associated with irinotecan plus bolus fluorouracil/leucovorin. J Clin Oncol 2002 0.75
21 Mathematical models to discriminate between benign and malignant adnexal masses: potential diagnostic improvement using ovarian HistoScanning. Int J Gynecol Cancer 2011 0.75
22 Too little benefit for too much toxicity: rethinking the adjuvant development model in colon cancer. Curr Opin Oncol 2016 0.75